Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

NCT03610438 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoid Leukemia

Interventions

DRUG: Inotuzumab Ozogamicin (IO)
DRUG: Inotuzumab Ozogamicin (IO)

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto